Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Large-scale analysis links glucose metabolism proteins to Alzheimer's disease biology

A team has identified Alzheimer's disease-specific proteins and processes that could be used for treatment targets and biomarkers.

13 Apr 2020

New clinical trial launches to test efficacy of cell therapy for severe COVID-19 cases

After a lightening round of proposals and reviews, an international team of scientists led by Dr. Camillo Ricordi was granted immediate FDA authorization for a 24-patient clinical trial to test the safety and exploratory efficacy of umbilical cord-derived mesenchymal stem cells to block the life-threatening lung inflammation that accompanies severe cases of COVID-19.

11 Apr 2020

Improper cellular cleanup during neurodevelopment may cause lifelong behavioral issues

Improper removal of faulty brain cells during neurodevelopment may cause lifelong behavioral issues, new research from the University of Virginia School of Medicine suggests.

9 Apr 2020

MBI may give important clues about early stages of dementia

In recent years, scientists have conducted more than 100 clinical trials in the hopes of finding new indicators capable of diagnosing Alzheimer's disease prior to the manifestation of clinical symptoms such as memory loss.

8 Apr 2020

Modifiable risk factors could play important role in Alzheimer's disease, study finds

Amyloid is a key feature of Alzheimer's disease, but the accumulation of these sticky proteins may not be the only risk factor for developing Alzheimer's disease, according to a new study published this week.

8 Apr 2020

New technology enables on-demand production of nutrients during space missions

On March 9, 2020, a Dragon cargo spacecraft arrived at the International Space Station carrying dozens of scientific experiments as a part of SpaceX's 20th cargo resupply mission. Now, Dragon heads home. On April 7, it is scheduled to undock from station, bringing samples, hardware and data from completed investigations back to Earth on its return trip.

8 Apr 2020

Alzheimer's disease: high amyloid levels linked to early disease

A new study published in the journal JAMA Neurology in April 2020 seems to indicate that higher brain amyloid levels represent early Alzheimer's disease (AD).

6 Apr 2020

New family of molecules to join altered receptors in Alzheimer's, Parkinson's and Huntington's

An article published in the Journal of Medicinal Chemistry shows a new family of molecules with high affinity to join imidazoline receptors, which are altered in the brain of those patients with neurodegenerative diseases such as Alzheimer's, Parkinson's and Huntington's.

3 Apr 2020

Researchers identify risk gene for Alzheimer's development

Researchers from the University of British Columbia and the Central South University in China have for the first time identified a gene that increases the risk of Alzheimer's disease.

1 Apr 2020

Amyloid plaque formation causes brain tissue loss in animals

Amyloid plaque formation directly causes brain tissue loss in animals, but a drug called lithium reduces the life-shortening effects of this loss, shows a study published today in eLife.

31 Mar 2020

Researchers discover new biomarker for early detection of Alzheimer's disease

Researchers at the University of California San Diego discovered that high blood levels of RNA produced by the PHGDH gene could serve as a biomarker for early detection of Alzheimer's disease.

31 Mar 2020

AGS commends Congress for prioritizing care for older adults in response to COVID-19

The American Geriatrics Society (AGS) today commended Congress and President Trump for supporting critical efforts to expand geriatrics expertise through the more than $2 trillion coronavirus stimulus package (S. 3548).

31 Mar 2020

Exercise-carrousel reduces the burden of dementia patient's caregivers

The research group "geriatric psychiatry in motion" of the German Sport University Cologne and the LVR-Hospital Cologne develop and evaluate exercise programs for geriatric mental health care.

30 Mar 2020

Scientists model human CMV-induced microcephaly using brain organoids

A City of Hope scientist is one step closer to discovering what weakens a pathogen that appears to cause babies to be born with abnormally small heads.

30 Mar 2020

Newly developed laboratory model helps reveal how HIV infection affects the brain

Though many negative repercussions of human immunodeficiency virus infection can be mitigated with the use of antiretroviral therapy, one area where medical advances haven't made as much progress is in the reduction of cognitive impacts.

27 Mar 2020

Alzheimer’s Society's media statement on the suspension of our services due to coronavirus

Kathryn Smith, Chief Operating Officer at Alzheimer's Society, has issued a statement with regards to the suspension of our services and events due to the coronavirus, also known as COVID-19.

27 Mar 2020

Coronavirus: Alzheimer's Society call to the Government on the COVID-19 outbreak

Coronavirus could pose a significant risk for people living with dementia in the UK – the Government must prioritise their welfare in the coming weeks.

27 Mar 2020

Alzheimer's Society responds to no increased spending on social care in budget

Alzheimer's Society responds to the Government's budget today, which included no additional investment in social care.

27 Mar 2020

Alzheimer's Society's response to Health Secretary Matt Hancock's cross-party social care announcement

Health and Social Care Secretary Matt Hancock has announced that the government will begin the process of cross party talks to find a long term solution to funding social care.

27 Mar 2020

Alzheimer's Society comment on media interest around day care centre closures

Chief Operating Officer at Alzheimer's Society, Kathryn Smith, comments on the recent media interest around day care centre closures for people affected by dementia.

27 Mar 2020

Alzheimer's Disease News and Research

Further Reading

Large-scale analysis links glucose metabolism proteins to Alzheimer's disease biology

New clinical trial launches to test efficacy of cell therapy for severe COVID-19 cases

Improper cellular cleanup during neurodevelopment may cause lifelong behavioral issues

MBI may give important clues about early stages of dementia

Modifiable risk factors could play important role in Alzheimer's disease, study finds

New technology enables on-demand production of nutrients during space missions

Alzheimer's disease: high amyloid levels linked to early disease

New family of molecules to join altered receptors in Alzheimer's, Parkinson's and Huntington's

Researchers identify risk gene for Alzheimer's development

Amyloid plaque formation causes brain tissue loss in animals

Researchers discover new biomarker for early detection of Alzheimer's disease

AGS commends Congress for prioritizing care for older adults in response to COVID-19

Exercise-carrousel reduces the burden of dementia patient's caregivers

Scientists model human CMV-induced microcephaly using brain organoids

Newly developed laboratory model helps reveal how HIV infection affects the brain

Alzheimer’s Society's media statement on the suspension of our services due to coronavirus

Coronavirus: Alzheimer's Society call to the Government on the COVID-19 outbreak

Alzheimer's Society responds to no increased spending on social care in budget

Alzheimer's Society's response to Health Secretary Matt Hancock's cross-party social care announcement

Alzheimer's Society comment on media interest around day care centre closures

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News